Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederik Damm

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Leukemia|August 9, 2025
The histone-methyltransferase DOT1L cooperates with LSD1 to control cell division in blast-phase MPNKarl Kapahnke, Thomas Plenge, Tabea Klaus, et al.
Haematologica|May 25, 2010
IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosisFelicitas Thol, Eva M Weissinger, Jürgen Krauter, et al.
Experimental Hematology & Oncology|October 29, 2025
Resolving intra-tumor heterogeneity and clonal evolution of core-binding factor acute myeloid leukemia patients with single-cell resolutionRaphael Hablesreiter, Paulina M Strzelecka, Klara Kopp, et al.
Journal for Immunotherapy of Cancer|April 10, 2025
Prior chemotherapy deteriorates T-cell quality for CAR T-cell therapy in B-cell non-Hodgkin's lymphomaCharlotte Junkuhn, Phillip Schiele, Anna Luzie Walter, et al.
Blood Cancer Journal|March 15, 2020
Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged miceVeronique Della-Valle, Damien Roos-Weil, Laurianne Scourzic, et al.
Leukemia|December 19, 2025
Dynamics of clonal hematopoiesis and cellular responses to stress-induced toxicity in autologous stem cell transplantationCatarina M Stein, Raphael Hablesreiter, Friederike Christen, et al.
Blood|April 28, 2010
Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemiaFelicitas Thol, Frederik Damm, Katharina Wagner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2011
Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemiaFelicitas Thol, Frederik Damm, Andrea Lüdeking, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2020
<i>TP53</i> Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 TrialMarianne Sinn, Bruno V Sinn, Denise Treue, et al.
Annals of Hematology|March 24, 2017
The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemiaAnna Both, Jürgen Krauter, Frederik Damm, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Leukemia|August 9, 2025
The histone-methyltransferase DOT1L cooperates with LSD1 to control cell division in blast-phase MPNKarl Kapahnke, Thomas Plenge, Tabea Klaus, et al.
Haematologica|May 25, 2010
IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosisFelicitas Thol, Eva M Weissinger, Jürgen Krauter, et al.
Experimental Hematology & Oncology|October 29, 2025
Resolving intra-tumor heterogeneity and clonal evolution of core-binding factor acute myeloid leukemia patients with single-cell resolutionRaphael Hablesreiter, Paulina M Strzelecka, Klara Kopp, et al.
Journal for Immunotherapy of Cancer|April 10, 2025
Prior chemotherapy deteriorates T-cell quality for CAR T-cell therapy in B-cell non-Hodgkin's lymphomaCharlotte Junkuhn, Phillip Schiele, Anna Luzie Walter, et al.
Blood Cancer Journal|March 15, 2020
Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged miceVeronique Della-Valle, Damien Roos-Weil, Laurianne Scourzic, et al.
Leukemia|December 19, 2025
Dynamics of clonal hematopoiesis and cellular responses to stress-induced toxicity in autologous stem cell transplantationCatarina M Stein, Raphael Hablesreiter, Friederike Christen, et al.
Blood|April 28, 2010
Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemiaFelicitas Thol, Frederik Damm, Katharina Wagner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2011
Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemiaFelicitas Thol, Frederik Damm, Andrea Lüdeking, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2020
<i>TP53</i> Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 TrialMarianne Sinn, Bruno V Sinn, Denise Treue, et al.
Annals of Hematology|March 24, 2017
The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemiaAnna Both, Jürgen Krauter, Frederik Damm, et al.
Pageof 7